Remove iv-compounding-service
article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations.

article thumbnail

Reducing Drug Spend with IV Robotic Services

Omnicell

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. The number of improperly prepared IVs is staggering. Sterile compounding is also one of the costliest functions in pharmacy operations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IV Robotics and the Latest USP Revisions

Omnicell

Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.

article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET. 23 at 1 pm ET.

article thumbnail

Driving Value Through Technology-as-a-Service

Omnicell

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

article thumbnail

Allegheny Health Network Innovates IV Medication Management Through Robotic Technology

Omnicell

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). We were highly dependent on purchasing ready-to-use IV medications from 503B vendors.

article thumbnail

Driving Safety and Savings Through System-Wide Sterile Compounding Automation

Omnicell

David Webster Director of Acute Care Pharmacy Operations, University of Rochester Medical Center Sterile compounding is one of the most high risk, high cost areas of medication management. Manual compounding is fraught with error, studies indicating 1 in 10 IVs are not prepared according to guidelines.